GZMB and rectal cancer: A study of 130 rectal cancers with CRT compared to a cohort group of 30 non‐radiated cancers showed a decrease in both CD3+ and CD8+ lymphocyte levels, while the ratio of cytotoxic CD8+/granzyme B+ cells increased [33].